In the realm of fine chemicals, certain compounds stand out due to their critical role in downstream applications, particularly within the pharmaceutical industry. 6-Hydroxy-3,4-dihydro-1H-quinolin-2-one, identified by CAS 54197-66-9, is one such compound. Its unique chemical structure and properties make it a valuable building block for complex organic synthesis, contributing significantly to the development of various therapeutic agents.

This quinolinone derivative, commonly found as an off-white to tan solid, is characterized by its specific melting point of 236-240°C and its molecular formula C9H9NO2. For procurement professionals and research chemists, understanding these specifications is fundamental to ensuring successful integration into synthetic pathways. Its high purity, often exceeding 95% as determined by HPLC, is a testament to its quality and suitability for demanding pharmaceutical applications.

The primary application of CAS 54197-66-9 lies in its function as a pharmaceutical intermediate. It is notably recognized as a metabolite of Cilostazol, a medication prescribed for peripheral artery disease. This association highlights its importance in drug metabolism studies and quality control for Cilostazol production. Researchers leverage this compound to investigate metabolic pathways, develop analytical standards, and ensure the purity of final drug products.

When seeking to purchase this essential chemical, identifying a trustworthy manufacturer or supplier is paramount. Leading chemical companies, especially those based in China, offer this intermediate with a commitment to quality and competitive pricing. For those looking to buy in bulk, it is advisable to inquire about production capabilities and supply chain reliability. The availability of a detailed Certificate of Analysis further solidifies the quality assurance for this critical fine chemical, ensuring that your sourcing decisions support robust pharmaceutical development.